{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T23:01:14Z","timestamp":1784761274207,"version":"3.55.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"RRI Impact"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Alpha-1-antitrypsin deficiency (AATD) is a rare genetic disorder leading to chronic obstructive pulmonary disease (COPD). Emphysema is the major structural damage visible on CT scans. However, there is little knowledge on the association between other structural abnormalities, such as bronchiectasis (BE), airway wall thickening (WT) or mucus plugs (MP), and clinical features.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>Retrospective study between 2008 and 2022 at one University Hospital of Bordeaux on all consecutive AATD patients. Bronchial and parenchymal alterations were evaluated with an (artificial intelligence) AI-driven Normalized Volume of Airway Abnormalities (NOVAA-CT) scoring system, including BE, WT, MP and emphysema quantifications. We evaluated correlations between forced expiratory volume in 1-s (FEV1%), dyspnea severity through the mMRC scale and the occurrence of at least one exacerbation in the year following CT scan.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Fifty-two AATD patients were included (median FEV1: 47% (40\u201365)). CT features of BE, WT and MP were present in 100%, 94.2% and 59% of the study population, respectively, with a lower versus upper lung predominance (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). WT (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) and BE (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.04) correlated with FEV1% but not mMRC (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009\u2265\u20090.09). Conversely, MP did not correlate with FEV1% (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.08) but with mMRC (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.01). Emphysema strongly correlated with both FEV1% and mMRC (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). In multivariate analysis, after adjustment for age, genotype and tobacco consumption, the best predictor of exacerbation was WT (OR\u2009=\u20091.12 [1.02\u20131.22];\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.01).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study demonstrates that AI-assisted identification of structural airway abnormalities is frequent in AATD patients and carries distinct clinical significance. Among them, WT was the most robust predictor of exacerbations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>\n                      <jats:bold>\n                        <jats:italic>Question<\/jats:italic>\n                      <\/jats:bold>\n                      <jats:italic>Emphysema is the major structural damage in alpha-1-antitrypsin deficiency (AATD). Clinical associations of bronchial abnormalities such as bronchiectasis (BE), mucus plugs (MP) and wall thickness (WT) are lacking.<\/jats:italic>\n                    <\/jats:p>\n                    <jats:p>\n                      <jats:bold>\n                        <jats:italic>Findings<\/jats:italic>\n                      <\/jats:bold>\n                      <jats:italic>Quantitative CT of BE and WT correlated with PFT (p\u2009\u2264\u20090.05), while MP correlated with dyspnea scale (p\u2009=\u20090.01). The best predictor of exacerbation was WT (OR\u2009=\u20091.12 [1.02\u20131.24]).<\/jats:italic>\n                    <\/jats:p>\n                    <jats:p>\n                      <jats:bold>\n                        <jats:italic>Clinical relevance<\/jats:italic>\n                      <\/jats:bold>\n                      <jats:italic>AI-assisted identification of bronchial abnormalities is frequent in AATD patients in addition to emphysema alone and carries distinct clinical significance. These findings highlight the importance of comprehensive CT-based evaluations to better characterize disease phenotype and guide clinical management in AATD.<\/jats:italic>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1007\/s00330-025-12188-7","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T12:33:30Z","timestamp":1765283610000},"page":"4098-4109","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Quantitative CT of emphysema, wall thickness and mucus plugs in alpha-1-antitrypsin deficiency: relationship to clinical outcomes"],"prefix":"10.1007","volume":"36","author":[{"given":"Ga\u00ebl","family":"Dournes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amel Imene","family":"Hadj Bouzid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klervi","family":"Doucet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilyes","family":"Benlala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Maurac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie","family":"Blanchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Dupin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Henrot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1459-2409","authenticated-orcid":false,"given":"Maeva","family":"Zysman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,9]]},"reference":[{"key":"12188_CR1","doi-asserted-by":"publisher","first-page":"4236","DOI":"10.1172\/JCI41196","volume":"120","author":"DA Bergin","year":"2010","unstructured":"Bergin DA, Reeves EP, Meleady P et al (2010) \u03b1-1 Antitrypsin regulates human neutrophil chemotaxis induced by soluble immune complexes and IL-8. J Clin Invest 120:4236\u20134250. https:\/\/doi.org\/10.1172\/JCI41196","journal-title":"J Clin Invest"},{"key":"12188_CR2","doi-asserted-by":"publisher","first-page":"162","DOI":"10.15326\/jcopdf.2020.0173","volume":"8","author":"DJ Smith","year":"2021","unstructured":"Smith DJ, Ellis PR, Turner AM (2021) Exacerbations of lung disease in alpha-1 antitrypsin deficiency. Chronic Obstr Pulm Dis 8:162\u2013176. https:\/\/doi.org\/10.15326\/jcopdf.2020.0173","journal-title":"Chronic Obstr Pulm Dis"},{"key":"12188_CR3","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1159\/000537759","volume":"103","author":"N Faria","year":"2024","unstructured":"Faria N, Gomes J, Guimar\u00e3es C, Mar\u00e7\u00f4a R, Ferraz B, Sucena M (2024) Predicting exacerbations in alpha-1 antitrypsin deficiency using clinical and pulmonary function tests: Portuguese EARCO Registry. Respiration 103:317\u2013325. https:\/\/doi.org\/10.1159\/000537759","journal-title":"Respiration"},{"key":"12188_CR4","doi-asserted-by":"publisher","first-page":"1800328","DOI":"10.1183\/13993003.00328-2018","volume":"52","author":"E Polverino","year":"2018","unstructured":"Polverino E, Dimakou K, Hurst J et al (2018) The overlap between bronchiectasis and chronic airway diseases: state of the art and future directions. Eur Respir J 52:1800328. https:\/\/doi.org\/10.1183\/13993003.00328-2018","journal-title":"Eur Respir J"},{"key":"12188_CR5","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1164\/rccm.200703-489OC","volume":"176","author":"DG Parr","year":"2007","unstructured":"Parr DG, Guest PG, Reynolds JH, Dowson LJ, Stockley RA (2007) Prevalence and impact of bronchiectasis in alpha1-antitrypsin deficiency. Am J Respir Crit Care Med 176:1215\u20131221. https:\/\/doi.org\/10.1164\/rccm.200703-489OC","journal-title":"Am J Respir Crit Care Med"},{"key":"12188_CR6","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.3390\/ijerph17072294","volume":"17","author":"A Sanduzzi","year":"2020","unstructured":"Sanduzzi A, Ciasullo E, Capitelli L, Zamparelli SS, Bocchino M (2020) Alpha-1-antitrypsin deficiency and bronchiectasis: a concomitance or a real association? Int J Environ Res Public Health 17:2294. https:\/\/doi.org\/10.3390\/ijerph17072294","journal-title":"Int J Environ Res Public Health"},{"key":"12188_CR7","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1164\/rccm.202006-2248OC","volume":"203","author":"EM Dunican","year":"2021","unstructured":"Dunican EM, Elicker BM, Henry T et al (2021) Mucus plugs and emphysema in the pathophysiology of airflow obstruction and hypoxemia in smokers. Am J Respir Crit Care Med 203:957\u2013968. https:\/\/doi.org\/10.1164\/rccm.202006-2248OC","journal-title":"Am J Respir Crit Care Med"},{"key":"12188_CR8","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1136\/thorax-2024-221928","volume":"80","author":"T van der Veer","year":"2025","unstructured":"van der Veer T, Andrinopoulou E-R, Braunstahl G-J et al (2025) Association between automatic AI-based quantification of airway-occlusive mucus plugs and all-cause mortality in patients with COPD. Thorax 80:105\u2013108. https:\/\/doi.org\/10.1136\/thorax-2024-221928","journal-title":"Thorax"},{"key":"12188_CR9","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1001\/jama.2023.2065","volume":"329","author":"AA Diaz","year":"2023","unstructured":"Diaz AA, Orejas JL, Grumley S et al (2023) Airway-occluding mucus plugs and mortality in patients with chronic obstructive pulmonary disease. JAMA 329:1832\u20131839. https:\/\/doi.org\/10.1001\/jama.2023.2065","journal-title":"JAMA"},{"key":"12188_CR10","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1007\/s00247-013-2867-y","volume":"44","author":"AD Calder","year":"2014","unstructured":"Calder AD, Bush A, Brody AS, Owens CM (2014) Scoring of chest CT in children with cystic fibrosis: state of the art. Pediatr Radiol 44:1496\u20131506","journal-title":"Pediatr Radiol"},{"key":"12188_CR11","doi-asserted-by":"publisher","first-page":"468","DOI":"10.3109\/15412550903341521","volume":"6","author":"T Yamashiro","year":"2009","unstructured":"Yamashiro T, Matsuoka S, Est\u00e9par RSJ et al (2009) Quantitative airway assessment on computed tomography in patients with alpha1-antitrypsin deficiency. COPD 6:468\u2013477. https:\/\/doi.org\/10.3109\/15412550903341521","journal-title":"COPD"},{"key":"12188_CR12","doi-asserted-by":"publisher","first-page":"2100844","DOI":"10.1183\/13993003.00844-2021","volume":"59","author":"G Dournes","year":"2022","unstructured":"Dournes G, Hall CS, Willmering MM et al (2022) Artificial intelligence in computed tomography for quantifying lung changes in the era of CFTR modulators. Eur Respir J 59:2100844. https:\/\/doi.org\/10.1183\/13993003.00844-2021","journal-title":"Eur Respir J"},{"key":"12188_CR13","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.rmr.2024.10.002","volume":"41","author":"G Dournes","year":"2024","unstructured":"Dournes G, Zysman M, Benlala I, Berger P (2024) [CT imaging of chronic obstructive pulmonary disease: what aspects and what role?]. Rev Mal Respir 41:738\u2013750. https:\/\/doi.org\/10.1016\/j.rmr.2024.10.002","journal-title":"Rev Mal Respir"},{"key":"12188_CR14","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/S0140-6736(15)60860-1","volume":"386","author":"KR Chapman","year":"2015","unstructured":"Chapman KR, Burdon JGW, Piitulainen E et al (2015) Intravenous augmentation treatment and lung density in severe \u03b11 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial. Lancet 386:360\u2013368. https:\/\/doi.org\/10.1016\/S0140-6736(15)60860-1","journal-title":"Lancet"},{"key":"12188_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-023-03048-6","volume":"21","author":"N White","year":"2023","unstructured":"White N, Parsons R, Collins G, Barnett A (2023) Evidence of questionable research practices in clinical prediction models. BMC Med 21:339. https:\/\/doi.org\/10.1186\/s12916-023-03048-6","journal-title":"BMC Med"},{"key":"12188_CR16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1148\/radiology.143.1.7063747","volume":"143","author":"JA Hanley","year":"1982","unstructured":"Hanley JA, McNeil BJ (1982) The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143:29\u201336. https:\/\/doi.org\/10.1148\/radiology.143.1.7063747","journal-title":"Radiology"},{"key":"12188_CR17","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1183\/09031936.05.00034805","volume":"26","author":"MR Miller","year":"2005","unstructured":"Miller MR, Hankinson J, Brusasco V (2005) Standardisation of spirometry. Eur Respir J 26:319\u2013338","journal-title":"Eur Respir J"},{"key":"12188_CR18","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1183\/09031936.05.00035005","volume":"26","author":"J Wanger","year":"2005","unstructured":"Wanger J, Clausen JL, Coates A et al (2005) Standardisation of the measurement of lung volumes. Eur Respir J 26:511\u2013522. https:\/\/doi.org\/10.1183\/09031936.05.00035005","journal-title":"Eur Respir J"},{"key":"12188_CR19","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1007\/s00330-024-11019-5","volume":"35","author":"AI Hadj Bouzid","year":"2025","unstructured":"Hadj Bouzid AI, Bui S, Benlala I et al (2025) Artificial intelligence-driven volumetric CT outcome score in cystic fibrosis: longitudinal and multicenter validation with\/without modulators treatment. Eur Radiol 35:815\u2013827. https:\/\/doi.org\/10.1007\/s00330-024-11019-5","journal-title":"Eur Radiol"},{"key":"12188_CR20","doi-asserted-by":"crossref","unstructured":"Bouzid AIH, De Senneville BD, Baldacci F et al (2024) CT evaluation of 2D and 3D holistic deep learning methods for the volumetric segmentation of airway lesions. In: Proceedings of the 2024 IEEE international symposium on biomedical imaging (ISBI). IEEE, Athens, pp 1\u20135. Available via https:\/\/ieeexplore.ieee.org\/document\/10635201. Accessed 18 May 2025","DOI":"10.1109\/ISBI56570.2024.10635201"},{"key":"12188_CR21","doi-asserted-by":"crossref","unstructured":"Bouzid AIH, Baldacci F, De Senneville BD et al (2025) 3D semantic segmentation of airway abnormalities on UTE-MRI with reinforcement learning on deep supervision. In: Proceedings of the 2025 IEEE 22nd international symposium on biomedical imaging (ISBI). IEEE, Houston, pp 1\u20135. Available via https:\/\/ieeexplore.ieee.org\/document\/10981041. Accessed 18 May 2025","DOI":"10.1109\/ISBI60581.2025.10981041"},{"key":"12188_CR22","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.232558","volume":"310","author":"AA Bankier","year":"2024","unstructured":"Bankier AA, MacMahon H, Colby T et al (2024) Fleischner Society: glossary of terms for thoracic imaging. Radiology 310:e232558. https:\/\/doi.org\/10.1148\/radiol.232558","journal-title":"Radiology"},{"key":"12188_CR23","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1164\/rccm.202410-2012SO","volume":"211","author":"R San Jos\u00e9 Est\u00e9par","year":"2025","unstructured":"San Jos\u00e9 Est\u00e9par R, Barr RG, Fain SB et al (2025) The use of CT densitometry for the assessment of emphysema in clinical trials: a position paper from the Fleischner Society. Am J Respir Crit Care Med 211:709\u2013728. https:\/\/doi.org\/10.1164\/rccm.202410-2012SO","journal-title":"Am J Respir Crit Care Med"},{"key":"12188_CR24","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10278-019-00223-1","volume":"33","author":"J Park","year":"2020","unstructured":"Park J, Yun J, Kim N et al (2020) Fully automated lung lobe segmentation in volumetric chest CT with 3D U-Net: validation with intra- and extra-datasets. J Digit Imaging 33:221\u2013230. https:\/\/doi.org\/10.1007\/s10278-019-00223-1","journal-title":"J Digit Imaging"},{"key":"12188_CR25","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1164\/rccm.202402-0411OC","volume":"210","author":"DR Mills","year":"2024","unstructured":"Mills DR, Masters IB, Yerkovich ST et al (2024) Radiographic outcomes in pediatric bronchiectasis and factors associated with reversibility. Am J Respir Crit Care Med 210:97\u2013107. https:\/\/doi.org\/10.1164\/rccm.202402-0411OC","journal-title":"Am J Respir Crit Care Med"},{"key":"12188_CR26","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1093\/aje\/kwk052","volume":"165","author":"E Vittinghoff","year":"2007","unstructured":"Vittinghoff E, McCulloch CE (2007) Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol 165:710\u2013718. https:\/\/doi.org\/10.1093\/aje\/kwk052","journal-title":"Am J Epidemiol"},{"key":"12188_CR27","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/s0895-4356(96)00236-3","volume":"49","author":"P Peduzzi","year":"1996","unstructured":"Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR (1996) A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 49:1373\u20131379. https:\/\/doi.org\/10.1016\/s0895-4356(96)00236-3","journal-title":"J Clin Epidemiol"},{"key":"12188_CR28","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1287\/mksc.1040.0070","volume":"23","author":"R Grewal","year":"2004","unstructured":"Grewal R, Cote JA, Baumgartner H (2004) Multicollinearity and measurement error in structural equation models: implications for theory testing. Mark Sci 23:519\u2013529. https:\/\/doi.org\/10.1287\/mksc.1040.0070","journal-title":"Mark Sci"},{"key":"12188_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-023-02830-2","volume":"18","author":"RA Stockley","year":"2023","unstructured":"Stockley RA, Pye A, De Soyza J et al (2023) The prevalence of bronchiectasis in patients with alpha-1 antitrypsin deficiency: initial report of EARCO. Orphanet J Rare Dis 18:243. https:\/\/doi.org\/10.1186\/s13023-023-02830-2","journal-title":"Orphanet J Rare Dis"},{"key":"12188_CR30","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1164\/ajrccm.162.4.9906120","volume":"162","author":"MC Pasteur","year":"2000","unstructured":"Pasteur MC, Helliwell SM, Houghton SJ et al (2000) An investigation into causative factors in patients with bronchiectasis. Am J Respir Crit Care Med 162:1277\u20131284. https:\/\/doi.org\/10.1164\/ajrccm.162.4.9906120","journal-title":"Am J Respir Crit Care Med"},{"key":"12188_CR31","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1136\/thoraxjnl-2019-214195","volume":"75","author":"L Carreto","year":"2020","unstructured":"Carreto L, Morrison M, Donovan J et al (2020) Utility of routine screening for alpha-1 antitrypsin deficiency in patients with bronchiectasis. Thorax 75:592\u2013593. https:\/\/doi.org\/10.1136\/thoraxjnl-2019-214195","journal-title":"Thorax"},{"key":"12188_CR32","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1378\/chest.117.2.415","volume":"117","author":"A Cuvelier","year":"2000","unstructured":"Cuvelier A, Muir JF, Hellot MF et al (2000) Distribution of alpha(1)-antitrypsin alleles in patients with bronchiectasis. Chest 117:415\u2013419. https:\/\/doi.org\/10.1378\/chest.117.2.415","journal-title":"Chest"},{"key":"12188_CR33","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/1465-9921-10-75","volume":"10","author":"DG Parr","year":"2009","unstructured":"Parr DG, Dirksen A, Piitulainen E, Deng C, Wencker M, Stockley RA (2009) Exploring the optimum approach to the use of CT densitometry in a randomised placebo-controlled study of augmentation therapy in alpha 1-antitrypsin deficiency. Respir Res 10:75. https:\/\/doi.org\/10.1186\/1465-9921-10-75","journal-title":"Respir Res"},{"key":"12188_CR34","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/S2213-2600(21)00277-0","volume":"10","author":"S Aliberti","year":"2022","unstructured":"Aliberti S, Goeminne PC, O\u2019Donnell AE et al (2022) Criteria and definitions for the radiological and clinical diagnosis of bronchiectasis in adults for use in clinical trials: international consensus recommendations. Lancet Respir Med 10:298\u2013306. https:\/\/doi.org\/10.1016\/S2213-2600(21)00277-0","journal-title":"Lancet Respir Med"},{"key":"12188_CR35","doi-asserted-by":"publisher","unstructured":"Li X, Feng S, Yang Y et al (2025) Association between airway mucus plugs and risk of moderate-to-severe exacerbations in patients with COPD: results from a Chinese prospective cohort study. Chest. https:\/\/doi.org\/10.1016\/j.chest.2025.03.026","DOI":"10.1016\/j.chest.2025.03.026"},{"key":"12188_CR36","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1056\/NEJMoa032158","volume":"350","author":"JC Hogg","year":"2004","unstructured":"Hogg JC, Chu F, Utokaparch S et al (2004) The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 350:2645\u20132653. https:\/\/doi.org\/10.1056\/NEJMoa032158","journal-title":"N Engl J Med"},{"key":"12188_CR37","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12931-023-02343-3","volume":"24","author":"N Kokturk","year":"2023","unstructured":"Kokturk N, Khodayari N, Lascano J, Riley EL, Brantly ML (2023) Lung inflammation in alpha-1-antitrypsin deficient individuals with normal lung function. Respir Res 24:40. https:\/\/doi.org\/10.1186\/s12931-023-02343-3","journal-title":"Respir Res"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-12188-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-025-12188-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-12188-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T11:23:00Z","timestamp":1776338580000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-025-12188-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,9]]},"references-count":37,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["12188"],"URL":"https:\/\/doi.org\/10.1007\/s00330-025-12188-7","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,9]]},"assertion":[{"value":"13 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The scientific guarantor of this publication is Gael Dournes.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare relationships with the following companies: Patrick Berger: GSK, AstraZeneca, Sanofi, Chiesi. Maeva Zysman: GSK, AstraZeneca, Menarini, Novartis, CSL Behring, Chiesi, Pfizer. Gael Dournes: Sanofi, AstraZeneca, Vertex Pharmaceuticals. The other authors do not have relationship of interest with the manuscript content.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"One of the authors (Patrick Berger) has significant statistical expertise. No complex statistical methods were necessary for this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was waived by the Institutional Review Board.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was obtained.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"None.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}